BioSpace News Archive

Policy

ReNeuron Expands Exosome IP Portfolio with Key Patent Grants

ReNeuron Group plc, a UK-based global leader in the development of cell-based therapeutics, announced that it has expanded its intellectual property estate via the grant of a number of key patents covering its exosome technology platform.

July 16, 2019
·
2 min read
Business

Rapid Dose Therapeutics Signs Distribution Agreement for QuickStrip™ Nutraceutical Product Line and Receives US$2.1 Million Purchase Order

Rapid Dose Therapeutics Corp. and Ukraine Pharma announced that they have signed a twelve month distribution agreement to export QuickStrip™ nutraceutical products to Ukraine and a number of other Eastern European countries, giving the Company rights to market the Energy, B12, and Sleep QuickStrip™ nutraceutical products to a consumer base of over 200 million people with tremendous buying power.

July 16, 2019
·
4 min read
BioCapital

1,000+ Maryland Prescribers Now Use DrFirst’s iPrescribe (SM) to Access the State’s PDMP and Keep Patients Safer

DrFirst and MedChi collaboration continues to enable better-informed prescribing decisions for state prescribers from within e-prescribing workflows

July 16, 2019
·
4 min read
Genetown

Telehealth Technology to Reduce Hospital Readmissions and Improve Outcomes for Cardiac Disease Patients

AMD Global Telemedicine adds MyNICaS™ hemodynamic monitoring technology to our portfolio of cardiac telehealth solutions, providing clinicans a solution to test cardiac patients in a matter of minutes and treat them in-place as needed.

July 16, 2019
·
2 min read
Deals

Cardiovascular Systems, Inc. to Webcast Fiscal 2019 Fourth-Quarter Earnings Conference Call Tuesday, August 6

Cardiovascular Systems, Inc. will host a live webcast of its fiscal 2019 fourth-quarter conference call on Tuesday, August 6, 2019, at 3:30 p.m. CT

July 16, 2019
·
1 min read
Deals

Checkmate Pharmaceuticals Announces Appointment of Alan Fuhrman to Board of Directors

Checkmate Pharmaceuticals Inc., a clinical stage biopharmaceutical company focused upon activation of innate immunity to treat advanced cancer, announced the addition of Alan Fuhrman to its Board of Directors.

July 16, 2019
·
2 min read
Business

Alnylam and 23andMe Collaborate on +MyFamily Program to Increase Awareness of TTR-Related Hereditary Amyloidosis

Companies share a commitment to supporting patients with this rare, underdiagnosed hereditary condition and are now offering more people the opportunity to learn about their health risk

July 16, 2019
·
5 min read
Policy

Ra Pharmaceuticals and Camurus Announce Exclusive License Agreement for FluidCrystal® Extended Release Formulation of Zilucoplan - July 16, 2019

FluidCrystal® extended release formulation of zilucoplan achieved rapid and sustained pharmacodynamic inhibition of complement C5 in non-human primates, supporting at least once weekly dosing

July 16, 2019
·
6 min read
Policy

MutantDx Raises the Bar for Early Cancer Detection

MutantDx announces the awarding of patents for their ultra-sensitive Liquid Biopsy technology by the United States and European Patent Offices.

July 16, 2019
·
2 min read
BiondVax Announces Rights Offering Fully Subscribed at US$20 Million

Funds to complete ongoing pivotal, clinical efficacy, Phase 3 trial of the M-001 Universal Flu Vaccine candidate and scale-up manufacturing

July 16, 2019
·
4 min read